Key Takeaways Psoriasis makes skin cells grow too fast, forming thick, scaly patchesGenes plus triggers like stress, ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat generalised pustular psoriasis (GPP) flares.

the Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) total score is 3 or more (at least moderate), and there are new or worsened pustules, and the GPPGA pustulation subscore is at ...

Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults. Last reviewed: 18 June 2025 Next review: This guidance will be reviewed if there is ...

Generalized pustular psoriasis may be caused or triggered by various factors, including genetic mutations, infections, and certain medications. Generalized pustular psoriasis (GPP) is a severe ...

Stress, infections, and corticosteroid withdrawal are known triggers of generalized pustular psoriasis (GPP). However, doctors cannot attribute every GPP flare to a specific cause. Psoriasis is an ...

"Generalized pustular psoriasis profoundly affects patients' physical and mental well-being, often disrupting their education, careers, and personal relationships. We are encouraged by the ...

SPEVIGO ® is a prescription medicine used to treat generalized pustular psoriasis (GPP) in adults and children 12 years of age and older who weigh at least 88 pounds (40 kg).

Generalized Pustular Psoriasis Market Outlook 2025-2035: The 7 major generalized pustular psoriasis market reached a value of USD 19.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to ...

Generalized pustular psoriasis (GPP): Accompanied by fever, chills, itching, fatigue, muscle weakness and change in heart rate, this can affect large areas of the body.